Sea You at Fetch Long Beach
|Articles|October 1, 2006

Canine Blood Test

Veterinary Diagnostics Institute Inc. (VDxI) announces the launch of Canine CardioCare, the first canine-specific N-terminal brain natriuretic peptide (NT-proBNP) blood test to detect heart disease in dogs.

Veterinary Diagnostics Institute Inc. (VDxI) announces the launch of Canine CardioCare, the first canine-specific N-terminal brain natriuretic peptide (NT-proBNP) blood test to detect heart disease in dogs.

Testing for NT-proBNP is recommended for all dogs age 6 and older as well as high-risk breeds, the company says.

In an independent clinical study, NT-proBNP was shown to be elevated by more than 10-fold in dogs with heart disease.

NT-proBNP is the preferred biomarker over BNP, the active hormone, as it has higher stability and hence higher values in disease states, according to the company.

For fastest response, visit

www.vdxinstitute.com


Related to this article

Q&A: Caregiver burden can begin early in pet illness. Are veterinary teams equipped to support clients, and how can veterinary social workers help both parties?
Caroline Cox, LSW, MSW, and Erika Krick, VMD, DACVIM (Oncology), discuss the role of veterinary social workers in supporting clients, communicating with veterinary teams, and helping practices address the human side of veterinary care in this Q&A from an interview at the 2026 Fetch National Harbor Veterinary Conference.